• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺相关病毒(AAV)为基础的基因治疗可预防神经病理学改变,并使高精氨酸血症小鼠正常发育认知能力。

AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse.

机构信息

Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA 90095-7054, USA.

出版信息

Gene Ther. 2013 Aug;20(8):785-96. doi: 10.1038/gt.2012.99. Epub 2013 Feb 7.

DOI:10.1038/gt.2012.99
PMID:23388701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3679314/
Abstract

Complete arginase I deficiency is the least severe urea cycle disorder, characterized by hyperargininemia and infrequent episodes of hyperammonemia. Patients suffer from neurological impairment with cortical and pyramidal tract deterioration, spasticity, loss of ambulation and seizures, and is associated with intellectual disability. In mice, onset is heralded by weight loss beginning around day 15; gait instability follows progressing to inability to stand and development of tail tremor with seizure-like activity and death. Here we report that hyperargininemic mice treated neonatally with an adeno-associated virus (AAV)-expressing arginase and followed long-term lack any presentation consistent with brain dysfunction. Behavioral and histopathological evaluation demonstrated that treated mice are indistinguishable from littermates, and that putative compounds associated with neurotoxicity are diminished. In addition, treatment results in near complete resolution of metabolic abnormalities early in life; however, there is the development of some derangement later with decline in transgene expression. Ammonium challenging revealed that treated mice are affected by exogenous loading much greater than littermates. These results demonstrate that AAV-based therapy for hyperargininemia is effective and prevents development of neurological abnormalities and cognitive dysfunction in a mouse model of hyperargininemia; however, nitrogen challenging reveals that these mice remain impaired in the handling of waste nitrogen.

摘要

完全精氨酰琥珀酸酶 I 缺乏症是最轻微的尿素循环障碍,其特征是高精氨酸血症和频繁的高氨血症发作。患者患有神经功能损伤,表现为皮质和锥体束恶化、痉挛、丧失行动能力和癫痫发作,并伴有智力障碍。在小鼠中,发病的标志是大约第 15 天开始体重减轻;随后出现步态不稳定,进展为无法站立,发展为尾巴震颤和类似癫痫发作的活动,最终导致死亡。在这里,我们报告说,在新生期用表达精氨酸酶的腺相关病毒(AAV)治疗高精氨酸血症的小鼠,长期缺乏任何与脑功能障碍一致的表现。行为学和组织病理学评估表明,治疗后的小鼠与同窝仔鼠无法区分,且与神经毒性相关的假定化合物减少。此外,治疗可在早期几乎完全纠正代谢异常;然而,随着转基因表达的下降,后期会出现一些紊乱。铵负荷挑战表明,治疗后的小鼠对外源负荷的影响比同窝仔鼠大得多。这些结果表明,基于 AAV 的高精氨酸血症治疗是有效的,可以预防高精氨酸血症小鼠模型中神经异常和认知功能障碍的发展;然而,氮负荷挑战表明,这些小鼠在处理废物氮方面仍然存在障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/752ecfc8feea/nihms427553f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/32280cbc7c83/nihms427553f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/d3e93bbc66d6/nihms427553f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/d15c00eca12d/nihms427553f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/ccc406e8870d/nihms427553f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/6a5288827595/nihms427553f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/3a7eee9e0793/nihms427553f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/95152d484cde/nihms427553f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/be499fd579b1/nihms427553f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/a67d91a03987/nihms427553f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/752ecfc8feea/nihms427553f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/32280cbc7c83/nihms427553f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/d3e93bbc66d6/nihms427553f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/d15c00eca12d/nihms427553f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/ccc406e8870d/nihms427553f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/6a5288827595/nihms427553f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/3a7eee9e0793/nihms427553f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/95152d484cde/nihms427553f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/be499fd579b1/nihms427553f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/a67d91a03987/nihms427553f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a9/3679314/752ecfc8feea/nihms427553f10.jpg

相似文献

1
AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse.腺相关病毒(AAV)为基础的基因治疗可预防神经病理学改变,并使高精氨酸血症小鼠正常发育认知能力。
Gene Ther. 2013 Aug;20(8):785-96. doi: 10.1038/gt.2012.99. Epub 2013 Feb 7.
2
Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy.在基于腺相关病毒(AAV)的基因疗法治疗的高精氨酸血症小鼠模型中,最低限度的尿素生成对于生存是必要的。
Gene Ther. 2015 Feb;22(2):111-5. doi: 10.1038/gt.2014.106. Epub 2014 Dec 4.
3
Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy.AAV 基因治疗可使幼年致死性精氨酸酶缺乏症小鼠长期存活。
Mol Ther. 2012 Oct;20(10):1844-51. doi: 10.1038/mt.2012.129. Epub 2012 Jul 3.
4
Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse.条件性晚发性精氨酸酶 1 缺乏症小鼠的致死表型。
Mol Genet Metab. 2013 Nov;110(3):222-30. doi: 10.1016/j.ymgme.2013.06.020. Epub 2013 Jul 6.
5
Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice.在精氨酸酶缺陷小鼠中,心肌细胞介导的精氨酸酶表达可控制高精氨酸血症,但不能控制高氨血症。
Mol Ther. 2014 Oct;22(10):1792-802. doi: 10.1038/mt.2014.99. Epub 2014 Jun 3.
6
Rescue of the Functional Alterations of Motor Cortical Circuits in Arginase Deficiency by Neonatal Gene Therapy.新生儿基因治疗对精氨酸酶缺乏症中运动皮质回路功能改变的挽救作用
J Neurosci. 2016 Jun 22;36(25):6680-90. doi: 10.1523/JNEUROSCI.0897-16.2016.
7
Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.肝精氨酸酶缺乏症促进出生后中枢神经系统发育过程中的脱髓鞘。
JCI Insight. 2019 Sep 5;4(17):130260. doi: 10.1172/jci.insight.130260.
8
Hyperargininemic Encephalopathy with Unique Clinical Presentation and Novel Genetic Mutations.高精氨酸血症性脑病变伴独特临床表现和新型基因突变。
J Coll Physicians Surg Pak. 2020 May;30(5):535-536. doi: 10.29271/jcpsp.2020.05.535.
9
Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia.高精氨酸血症小鼠模型中血浆和组织胍基化合物增加。
Mol Genet Metab. 2008 Feb;93(2):172-8. doi: 10.1016/j.ymgme.2007.09.016. Epub 2007 Nov 7.
10
Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.使用辅助依赖型腺病毒载体对新生小鼠模型中的精氨酸酶缺乏症进行短期纠正。
Mol Ther. 2009 Jul;17(7):1155-63. doi: 10.1038/mt.2009.65. Epub 2009 Apr 14.

引用本文的文献

1
Updated Gene Therapy for Renal Inborn Errors of Metabolism.用于肾脏先天性代谢缺陷的更新基因疗法。
Genes (Basel). 2025 Apr 29;16(5):516. doi: 10.3390/genes16050516.
2
Gene therapy for urea cycle defects: An update from historical perspectives to future prospects.尿素循环缺陷的基因治疗:从历史展望未来。
J Inherit Metab Dis. 2024 Jan;47(1):50-62. doi: 10.1002/jimd.12609. Epub 2023 Apr 18.
3
Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice.

本文引用的文献

1
Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy.AAV 基因治疗可使幼年致死性精氨酸酶缺乏症小鼠长期存活。
Mol Ther. 2012 Oct;20(10):1844-51. doi: 10.1038/mt.2012.129. Epub 2012 Jul 3.
2
AAV-based neonatal gene therapy for hemophilia A: long-term correction and avoidance of immune responses in mice.基于腺相关病毒的新生儿基因治疗血友病 A:在小鼠中实现长期纠正和避免免疫反应。
Gene Ther. 2012 Dec;19(12):1166-76. doi: 10.1038/gt.2011.200. Epub 2012 Jan 12.
3
Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?
基因治疗联合氮清除剂预处理纠正婴儿瓜氨酸血症 1 型小鼠的生化和行为异常。
Int J Mol Sci. 2022 Nov 29;23(23):14940. doi: 10.3390/ijms232314940.
4
The role and control of arginine levels in arginase 1 deficiency.精氨酸水平在精氨酸酶 1 缺乏症中的作用和调控。
J Inherit Metab Dis. 2023 Jan;46(1):3-14. doi: 10.1002/jimd.12564. Epub 2022 Oct 13.
5
Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiency.间歇性给予脂质纳米颗粒信使核糖核酸可预防与精氨酸酶缺乏相关的皮质脱髓鞘。
Mol Ther Nucleic Acids. 2022 Apr 27;28:859-874. doi: 10.1016/j.omtn.2022.04.012. eCollection 2022 Jun 14.
6
Gene therapy for guanidinoacetate methyltransferase deficiency restores cerebral and myocardial creatine while resolving behavioral abnormalities.针对胍基乙酸甲基转移酶缺乏症的基因疗法可恢复大脑和心肌中的肌酸,同时解决行为异常问题。
Mol Ther Methods Clin Dev. 2022 Mar 28;25:278-296. doi: 10.1016/j.omtm.2022.03.015. eCollection 2022 Jun 9.
7
Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.靶向脂质纳米颗粒的 mRNA 疗法治疗遗传性代谢性肝脏疾病精氨酸酶缺乏症。
Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21150-21159. doi: 10.1073/pnas.1906182116. Epub 2019 Sep 9.
8
Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.肝精氨酸酶缺乏症促进出生后中枢神经系统发育过程中的脱髓鞘。
JCI Insight. 2019 Sep 5;4(17):130260. doi: 10.1172/jci.insight.130260.
9
The Arginase Pathway in Neonatal Brain Hypoxia-Ischemia.新生儿脑缺氧缺血中的精氨酸酶途径
Dev Neurosci. 2018;40(5-6):437-450. doi: 10.1159/000496467. Epub 2019 Apr 17.
10
Human hepatocyte transplantation corrects the inherited metabolic liver disorder arginase deficiency in mice.人肝细胞移植纠正了小鼠遗传性代谢性肝脏疾病精氨酸酶缺乏症。
Mol Genet Metab. 2018 Jun;124(2):114-123. doi: 10.1016/j.ymgme.2018.04.005. Epub 2018 Apr 21.
精氨酸酶 1 缺乏症:高氨血症所致严重婴儿型起病:比报道的更常见?
Mol Genet Metab. 2011 Sep-Oct;104(1-2):107-11. doi: 10.1016/j.ymgme.2011.06.025. Epub 2011 Jul 13.
4
RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy.与天然 AAV 血清型相比,RH10 可在新生鼠基因治疗中提供更优的转基因表达。
J Gene Med. 2010 Sep;12(9):766-78. doi: 10.1002/jgm.1496.
5
Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia.精氨酸血症患者血液、脑脊液和尸检脑组织中的胍基化合物水平。
Mol Genet Metab. 2010;100 Suppl 1:S31-6. doi: 10.1016/j.ymgme.2010.01.012. Epub 2010 Jan 29.
6
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents.使用高架十字迷宫作为啮齿动物焦虑相关行为的一种测定方法。
Nat Protoc. 2007;2(2):322-8. doi: 10.1038/nprot.2007.44.
7
Morris water maze: procedures for assessing spatial and related forms of learning and memory.莫里斯水迷宫:评估空间及相关形式学习与记忆的程序。
Nat Protoc. 2006;1(2):848-58. doi: 10.1038/nprot.2006.116.
8
NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice.N-甲基-D-天冬氨酸(NMDA)受体拮抗作用会破坏雄性C57BL/6J小鼠吗啡镇痛耐受性的形成,但对雌性小鼠没有影响。
Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R315-26. doi: 10.1152/ajpregu.00831.2005. Epub 2006 Apr 6.
9
Small animal imaging center design: the facility at the UCLA Crump Institute for Molecular Imaging.小动物成像中心设计:加州大学洛杉矶分校克伦普分子成像研究所的设施
Mol Imaging Biol. 2005 Nov-Dec;7(6):393-402. doi: 10.1007/s11307-005-0015-2.
10
NIH Swiss and Black Swiss mice have retinal degeneration and performance deficits in cognitive tests.美国国立卫生研究院瑞士小鼠和黑瑞士小鼠存在视网膜退化以及在认知测试中表现出缺陷。
Comp Med. 2005 Aug;55(4):310-6.